Target type: biologicalprocess
Any process that modulates the frequency, rate or extent of apoptotic signaling pathway. [GOC:mtg_apoptosis]
Apoptosis, a tightly regulated cellular process, is essential for maintaining tissue homeostasis and eliminating damaged or unwanted cells. The regulation of the apoptotic signaling pathway involves a complex interplay of signaling molecules, receptors, and effector proteins.
The process can be initiated by various stimuli, including:
- **Intrinsic Pathway (Mitochondrial Pathway):** Triggered by intracellular stress, such as DNA damage, growth factor deprivation, or hypoxia.
- **Release of Cytochrome c:** Stress signals activate pro-apoptotic proteins like BAX and BAK, which permeabilize the mitochondrial outer membrane, leading to the release of cytochrome c into the cytosol.
- **Apoptosome Formation:** Cytochrome c binds to the adaptor protein Apaf-1, which then recruits the procaspase-9. This complex, called the apoptosome, activates caspase-9.
- **Caspase Cascade:** Activated caspase-9, a key initiator caspase, activates effector caspases (caspase-3, -6, and -7).
- **Execution of Apoptosis:** Effector caspases dismantle cellular components, leading to characteristic apoptotic features, including DNA fragmentation, nuclear condensation, and cell shrinkage.
- **Extrinsic Pathway (Death Receptor Pathway):** Triggered by external signals, such as the binding of death ligands (TNF-α, TRAIL, FasL) to their respective death receptors (TNFR1, TRAIL-R1/2, Fas).
- **Recruitment of Adaptor Proteins:** Ligand binding to death receptors recruits adaptor proteins like FADD (Fas-associated protein with death domain) and TRADD (TNF receptor-associated death domain protein).
- **Caspase-8 Activation:** FADD and TRADD assemble a death-inducing signaling complex (DISC), which activates caspase-8, an initiator caspase.
- **Caspase Cascade:** Caspase-8 can directly activate effector caspases or activate caspase-3 indirectly through the mitochondrial pathway.
**Regulation of Apoptotic Signaling Pathway:**
- **Anti-apoptotic Proteins:** Proteins like Bcl-2, Bcl-xL, and Mcl-1 inhibit apoptosis by preventing the release of cytochrome c from mitochondria.
- **Pro-apoptotic Proteins:** Proteins like Bax, Bak, and Bid promote apoptosis by facilitating mitochondrial permeabilization.
- **Inhibitors of Caspases:** IAPs (inhibitors of apoptosis proteins) directly bind to and inhibit effector caspases, preventing their activation.
- **Survival Factors:** Growth factors and other survival signals can activate survival pathways, which upregulate anti-apoptotic proteins and inhibit pro-apoptotic proteins.
**Significance of Apoptosis Regulation:**
- **Maintaining Tissue Homeostasis:** Apoptosis eliminates damaged or unwanted cells, preventing the accumulation of potentially harmful cells.
- **Development and Morphogenesis:** Apoptosis is crucial for shaping tissues and organs during development.
- **Immune System Regulation:** Apoptosis removes cells that are no longer needed, such as lymphocytes after an immune response.
- **Cancer Prevention:** Dysregulation of apoptosis can contribute to cancer development.
The intricate regulation of the apoptotic signaling pathway ensures that apoptosis occurs only when necessary, maintaining cellular and tissue integrity.'
"
Protein | Definition | Taxonomy |
---|---|---|
Peptidyl-prolyl cis-trans isomerase A | A peptidyl-prolyl cis-trans isomerase A that is encoded in the genome of human. [PRO:DNx, UniProtKB:P62937] | Homo sapiens (human) |
Compound | Definition | Classes | Roles |
---|---|---|---|
2,4-pyridinedicarboxylic acid | lutidinic acid : A pyridinedicarboxylic acid carrying carboxy groups at positions 2 and 4. | pyridinedicarboxylic acid | |
daminozide | daminozide: induces tumors | straight-chain fatty acid | |
prolinal | pyrrolidines | ||
oxalylglycine | N-oxalylglycine : An amino dicarboxylic acid that is iminodiacetic acid with an oxo substituent. It is used as an inhibitor of alpha-ketoglutarate dependent (EC 1.14.11.*) enzymes. oxalylglycine: structure given in first source | amino dicarboxylic acid; N-acylglycine | EC 1.14.11.* (oxidoreductase acting on paired donors, 2-oxoglutarate as one donor, incorporating 1 atom each of oxygen into both donors) inhibitor |
cyclosporine | ramihyphin A: one of the metabolites produced by Fusarium sp. S-435; RN given refers to cpd with unknown MF | homodetic cyclic peptide | anti-asthmatic drug; anticoronaviral agent; antifungal agent; antirheumatic drug; carcinogenic agent; dermatologic drug; EC 3.1.3.16 (phosphoprotein phosphatase) inhibitor; geroprotector; immunosuppressive agent; metabolite |
sanglifehrin a | sanglifehrin A: binds cyclophilin A; isolated from Streptomyces; structure in first source | ||
(melle-4)cyclosporin | (melle-4)cyclosporin: a non-immunosuppressive analog of cyclosporin A | ||
cyclosporin g | cyclosporin G: similar immunosuppressive actions as cyclosporin, but without nephrotoxic side effects; cyclosporin A analog; MW 1217 | ||
scy-635 | |||
alisporivir | alisporivir: nonimmunosuppressive cyclosporin analog; structure/sequence in first source | homodetic cyclic peptide | anticoronaviral agent |